Get the Stockscreener App
38.55
0.36%
-0.14
After Hours:
39.00
0.45
+1.17%
Exelixis Inc Stock (EXEL) Latest News
Peering Into Exelixis's Recent Short Interest - Benzinga
Is Exelixis, Inc. (EXEL) The Best Immunology Stock To Buy Now? - Insider Monkey
10 Best Immunology Stocks To Buy Now - Insider Monkey
Exelixis director Jack Wyszomierski sells $331,430 in stock By Investing.com - Investing.com Canada
Exelixis director Jack Wyszomierski sells $331,430 in stock - Investing.com India
Exelixis director Julie Smith sells $2.8 million in stock - Investing.com
Exelixis Directors Execute Significant Stock Transactions - TradingView
BioInvent announces achievement of a research milestone event in its collaboration with Exelixis triggering a USD 1 million milestone payment - ACCESS Newswire
Exelixis focuses on future growth despite COSMIC-313 trial challenges - Yahoo Finance
Exelixis, Inc. to Host Earnings Call - ACCESS Newswire
Exelixis CFO Christopher Senner sells $1.06 million in stock By Investing.com - Investing.com South Africa
Exelixis CSO Aftab Dana sells shares worth $991,772 By Investing.com - Investing.com South Africa
When (EXEL) Moves Investors should Listen - Stock Traders Daily
Exelixis EVP Haley Patrick sells $1.95 million in company stock By Investing.com - Investing.com South Africa
Exelixis Stock: Executives Sell as Shares Near Peak - sharewise
Exelixis director Oliver Bob sells $694,600 in stock By Investing.com - Investing.com South Africa
Exelixis CFO Christopher Senner sells $1.06 million in stock - Investing.com India
Exelixis director Oliver Bob sells $694,600 in stock - Investing.com India
Exelixis Executives and Director Sell Shares - TradingView
Exelixis stock hits 52-week high at $37.63 amid robust growth By Investing.com - Investing.com South Africa
Exelixis stock hits 52-week high at $37.63 amid robust growth - Investing.com India
Zacks.com featured highlights Gilead Sciences, Exelixis, Synchrony Financial and Molson Coors - Yahoo Finance
Exelixis to Webcast Fireside Chats at Upcoming Investor Conferences in March - Business Wire
This Conagra Brands Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
Wells Fargo Downgrades Exelixis to Equalweight From Overweight, Price Target is $36 - Marketscreener.com
Exelixis, Inc. (EXEL): Among Renaissance Technologies Portfolio’s Top Stock Picks - Insider Monkey
Exelixis, Inc. (NASDAQ:EXEL) Director Sells $425,884.80 in Stock - MarketBeat
Exelixis Gains 6.7% Post Q4 Earnings: Is This the Right Time to Buy? - MSN
Exelixis (EXEL) Stock Jumps Amid New Share Buyback Announcement - GuruFocus.com
Why Exelixis Stock Trounced the Market on Thursday - MSN
Why Is Cancer-Focused Exelixis Stock Trading Higher On Friday? - AOL
Why Exelixis Shares Are Skyrocketing: A Story of Triumph and Strategy - Jomfruland.net
Exelixis' (NASDAQ:EXEL) Earnings May Just Be The Starting Point - Yahoo Finance
Exelixis Inc.: Pipeline Expansion & Innovation to Build A Robust Portfolio! - Smartkarma
Exelixis Board Authorizes Additional Share Buyback Program of Up To $500 Million; Shares Advance After Hours - Marketscreener.com
Exelixis Approves Additional $500 Mln Stock Buyback Program - Nasdaq
Exelixis Announces a Newly Authorized $500 Million Stock Repurchase Program - The Bakersfield Californian
Is Exelixis (EXEL) a Solid Growth Stock? 3 Reasons to Think "Yes" - MSN
Exelixis director Sue Gail Eckhardt sells shares worth $405,111 By Investing.com - Investing.com South Africa
Exelixis director George Poste sells $551,462 in stock By Investing.com - Investing.com Australia
Exelixis director Mary Beckerle sells $425,878 in stock By Investing.com - Investing.com Australia
Exelixis director Sue Gail Eckhardt sells shares worth $405,111 - Investing.com India
Exelixis director George Poste sells $551,462 in stock - Investing.com India
Exelixis director Mary Beckerle sells $425,878 in stock - Investing.com India
Exelixis director Freire Maria C sells $1.54 million in stock By Investing.com - Investing.com Nigeria
Exelixis Executives Sell Shares in February Transactions - TradingView
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):